Representative Sharice Davids Tours Local Medical Device Supplier Affected by Semiconductor Shortage, Calls for Supply Chain Solutions

Published in Government Relations on January 27, 2022

This message is shared on behalf of MAMES

This week, Representative Sharice Davids toured Cherub Medical Supplies, a Shawnee-based supplier of pediatric medical devices that is grappling with long delays due to the current shortage of critical materials like semiconductors. Davids joined Cherub and another local company, Lenexa-based Reliable Medical Supplies, to urge passage of legislation that would reduce our reliance on foreign-made materials and deliver these lifesaving devices to Kansans in need.

Rep. Sharice Davids speaks with Cherub Medical Supply Director of Operations Sam Cress.

(Rep. Sharice Davids speaks with Cherub Medical Supply Director of Operations Sam Cress.)

“These local businesses are doing their best to work around supply chain issues and get lifesaving machines to the children and adults who are dependent on them to stay healthy, but we can be doing more to help them,” said Davids. “I’m working to get legislation like the CHIPS Act across the finish line so that we can strengthen our domestic supply chain, lower costs, and make these critical materials here at home.”
 
Semiconductors, or chips, are necessary components of many medical devices, including the CPAP machines provided by Cherub and Reliable to over 72,000 sleep apnea patients in the Kansas Third District. The current global chip shortage has contributed to inflation on goods from cars to smartphones—and to a growing waitlist for lifesaving medical devices. Cherub works primarily with kids who need these machines to return home safely from the hospital, supplying home medical equipment such as oxygen monitors and ventilators. Reliable serves over 800 clients in the Kansas City area, including nursing homes.
 
“As a small business caring for medically fragile children in Kansas City, we have faced many issues due to rising costs, semiconductor supply chain shortages, and declining reimbursement. We look forward to partnering with Rep. Davids regarding these concerns to champion and protect the families we serve,” said Sam Cress, Director of Operations at Cherub Medical Supply.
 
Davids has been a vocal proponent of the bipartisan CHIPS Act, which would boost domestic manufacturing of these critical materials and reduce our dependence on foreign-made goods. It currrently awaits full funding through the U.S. Innovation and Competition Act, which has been passed by the House and the Senate. If funded, it would provide $52 billion to strengthen domestic semiconductor production, including $2 billion targeted to the research and development of mature node semiconductors, known as legacy chips, which are critical for medical devices, smartphones, cars, computers, and more.
 
“As a local provider of home medical equipment, we are experiencing unprecedented interruptions as we try to provide for our patients. The shortage of semiconductor chips has meant long backorders for equipment and uneasy delivery times for our patients.  We look forward to working with Rep. Davids and her colleagues on the Hill to find ways to remedy this situation,” said Nick Hulsing, Owner of Reliable Medical Supply.
 
Davids has been actively working to reduce global supply chain issues and lower costs for businesses and consumers. She introduced the SUPPLIES Act, which create a $100 million grant program for small and medium manufacturers that shift their production to manufacture PPE and testing supplies during future public health emergencies. It would also prioritize manufacturing these supplies domestically, reducing our country’s dependence on foreign countries for medical supplies and eliminating price gouging of life-saving materials. 

Rep. Sharice Davids tours Cherub Medical Supply in Shawnee, Kansas

(Rep. Sharice Davids tours Cherub Medical Supply in Shawnee, Kansas)


TAGS

  1. state association
  2. supply chain
  3. vgm government

From Our Experts

Bipartisan Medicare O&P Bill Introduced thumbnail Bipartisan Medicare O&P Bill Introduced In a timely move ahead of next week's NAAOP Legislative Fly-In, a bipartisan group of lawmakers introduced the Medicare Orthotics and Prosthetics Patient-Centered Care Act, a bill aimed at improving access to high-quality orthotic and prosthetic care for Medicare beneficiaries. The Patient-Centered Care Act seeks to address critical gaps in Medicare coverage for orthotic and prosthetic (O&P) services. Under current rules, beneficiaries may receive devices without the necessary clinical services Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.